Skip to main content
. 2019 Sep 24;10:2042098619876737. doi: 10.1177/2042098619876737

Figure 4.

Figure 4.

Sequential analyses of aROR of GI bleeding in apixaban, dabigatran, rivaroxaban, and warfarin in KIDS-KD 2012–2016.

Adjusted for age and gender; Vertical bars represent 95% CIs.

aROR, adjusted reporting odds ratio; CI, confidence interval; GI, gastrointestinal; KIDS-KD, Korea Institute of Drug Safety and Risk Management (KIDS)-Korea Adverse Event Reporting System (KAERS) database.